Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (236)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2024
509
1.110
 Why?
Germ-Line Mutation
9
2013
61
1.090
 Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.090
 Why?
PTEN Phosphohydrolase
13
2015
55
1.060
 Why?
Barrett Esophagus
2
2019
29
1.030
 Why?
Esophageal Neoplasms
2
2019
100
0.950
 Why?
Adenocarcinoma
3
2019
397
0.850
 Why?
Haplotypes
3
2020
84
0.790
 Why?
Homozygote
3
2019
57
0.680
 Why?
Polymorphism, Single Nucleotide
9
2021
485
0.670
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
154
0.640
 Why?
Proto-Oncogene Proteins c-akt
4
2012
157
0.600
 Why?
Databases, Factual
1
2020
657
0.570
 Why?
Alleles
6
2021
251
0.470
 Why?
Lung Neoplasms
3
2020
605
0.460
 Why?
Phosphatidylinositol 3-Kinases
2
2012
140
0.420
 Why?
Genotype
6
2021
534
0.410
 Why?
Scavenger Receptors, Class A
1
2011
39
0.380
 Why?
Extracellular Matrix Proteins
1
2011
69
0.380
 Why?
Genetic Variation
3
2021
213
0.300
 Why?
Transcription Factors
1
2011
564
0.300
 Why?
Breast Neoplasms
7
2017
1179
0.290
 Why?
Humans
37
2024
50208
0.290
 Why?
Thyroid Neoplasms
4
2012
111
0.290
 Why?
Heart Defects, Congenital
2
2024
585
0.280
 Why?
Case-Control Studies
4
2024
1126
0.270
 Why?
Genes, Wilms Tumor
1
2005
1
0.250
 Why?
Population
1
2005
8
0.250
 Why?
Gene Frequency
3
2020
94
0.250
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.250
 Why?
Genome
2
2019
65
0.240
 Why?
Lamin Type A
1
2024
6
0.240
 Why?
Capacity Building
1
2024
18
0.230
 Why?
DNA Methylation
3
2024
550
0.220
 Why?
Adult
16
2024
13324
0.220
 Why?
Middle Aged
16
2021
12206
0.220
 Why?
Linkage Disequilibrium
2
2020
37
0.220
 Why?
Female
21
2024
26635
0.210
 Why?
Smoke-Free Policy
1
2022
8
0.210
 Why?
Tobacco Smoke Pollution
1
2022
48
0.200
 Why?
Inheritance Patterns
1
2021
22
0.190
 Why?
Phenotype
7
2021
733
0.190
 Why?
Models, Genetic
5
2013
170
0.180
 Why?
Risk Factors
5
2019
3629
0.180
 Why?
Male
15
2024
25399
0.180
 Why?
Succinate Dehydrogenase
2
2011
23
0.180
 Why?
Stilbenes
2
2010
56
0.180
 Why?
Aged
11
2020
9405
0.180
 Why?
Fires
1
2020
14
0.170
 Why?
Agriculture
1
2020
17
0.170
 Why?
Social Media
1
2021
96
0.170
 Why?
Tobacco Products
1
2021
119
0.170
 Why?
Cluster Analysis
4
2013
235
0.170
 Why?
Aged, 80 and over
5
2020
3154
0.170
 Why?
Exome
1
2019
46
0.170
 Why?
Genomics
1
2020
285
0.160
 Why?
Cell Proliferation
3
2010
1013
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
131
0.150
 Why?
Prostatic Neoplasms
2
2012
394
0.150
 Why?
Gene Expression Regulation, Neoplastic
3
2010
828
0.140
 Why?
Prognosis
2
2020
1954
0.140
 Why?
Endometrial Neoplasms
2
2015
138
0.140
 Why?
Leprosy
1
2016
6
0.140
 Why?
Asthma
1
2020
280
0.130
 Why?
Hypertension
1
2021
537
0.130
 Why?
Emergency Service, Hospital
1
2020
484
0.130
 Why?
Microsatellite Repeats
2
2012
37
0.130
 Why?
Regression Analysis
2
2017
395
0.130
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
146
0.120
 Why?
Arkansas
4
2024
1985
0.120
 Why?
Genetic Linkage
2
2011
26
0.120
 Why?
Young Adult
7
2021
3981
0.110
 Why?
Sirolimus
2
2010
62
0.110
 Why?
Adolescent
8
2021
6390
0.110
 Why?
Genome-Wide Association Study
2
2012
166
0.110
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
 Why?
Smad4 Protein
1
2013
5
0.110
 Why?
Genetic Testing
2
2010
119
0.110
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
18
0.110
 Why?
Cohort Studies
3
2012
1422
0.110
 Why?
Colonic Polyps
1
2013
35
0.110
 Why?
Mitochondrial Diseases
1
2012
42
0.100
 Why?
Receptors, Cell Surface
1
2013
125
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.100
 Why?
NAD
1
2011
43
0.100
 Why?
Antigens, CD
1
2013
221
0.100
 Why?
Genes, p53
1
2011
51
0.100
 Why?
DNA, Neoplasm
1
2012
147
0.100
 Why?
Siblings
1
2011
34
0.100
 Why?
Mutation, Missense
1
2012
105
0.100
 Why?
Taxoids
1
2011
37
0.100
 Why?
Gene Expression Profiling
3
2012
1037
0.100
 Why?
Adenoma
1
2012
110
0.100
 Why?
Risk
1
2012
324
0.090
 Why?
Colorectal Neoplasms
2
2012
236
0.090
 Why?
Software
1
2013
271
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Receptors, Androgen
1
2010
46
0.090
 Why?
Cephalometry
1
2010
17
0.090
 Why?
Tumor Microenvironment
1
2012
233
0.090
 Why?
Gene Dosage
1
2009
78
0.090
 Why?
Head
1
2010
73
0.090
 Why?
Carcinoma, Transitional Cell
1
2010
52
0.090
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
143
0.080
 Why?
Patient Selection
1
2010
253
0.080
 Why?
Cell Communication
1
2009
69
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
314
0.080
 Why?
Age Factors
1
2012
1092
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
156
0.080
 Why?
Immunohistochemistry
1
2011
978
0.080
 Why?
Smoking
1
2012
512
0.080
 Why?
Prevalence
2
2021
951
0.070
 Why?
Chromosome Mapping
2
2021
156
0.070
 Why?
Prospective Studies
4
2017
2379
0.070
 Why?
Mass Screening
1
2010
346
0.070
 Why?
Rural Population
2
2022
537
0.070
 Why?
Cell Line, Tumor
4
2011
1416
0.070
 Why?
Physical Chromosome Mapping
1
2005
8
0.070
 Why?
Multiple Myeloma
1
2020
2954
0.070
 Why?
Antineoplastic Agents
2
2011
1186
0.070
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
Exons
1
2005
95
0.060
 Why?
Child
5
2020
6851
0.060
 Why?
CpG Islands
1
2024
107
0.060
 Why?
Models, Theoretical
1
2005
174
0.060
 Why?
Gene Expression Regulation
1
2008
979
0.060
 Why?
Mutation
2
2010
1294
0.060
 Why?
Biopsy
1
2005
590
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3883
0.050
 Why?
Risk Assessment
2
2021
1262
0.050
 Why?
Phosphoproteins
1
2022
108
0.050
 Why?
RNA, Viral
1
2022
126
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
91
0.050
 Why?
Azacitidine
1
2020
34
0.050
 Why?
Membrane Glycoproteins
1
2022
246
0.050
 Why?
Nutrition Surveys
1
2021
103
0.050
 Why?
Loss of Heterozygosity
2
2012
77
0.050
 Why?
United States
2
2021
4874
0.050
 Why?
Stromal Cells
2
2012
72
0.050
 Why?
TOR Serine-Threonine Kinases
2
2010
77
0.040
 Why?
Nicotine
1
2021
187
0.040
 Why?
Self Report
1
2021
199
0.040
 Why?
Pedigree
2
2010
125
0.040
 Why?
Seasons
1
2020
82
0.040
 Why?
Air Pollution
1
2020
42
0.040
 Why?
Odds Ratio
1
2021
546
0.040
 Why?
Neoplasms
1
2009
1249
0.040
 Why?
Signal Transduction
3
2010
1622
0.040
 Why?
Phosphorylation
2
2010
534
0.040
 Why?
Sensitivity and Specificity
2
2012
863
0.040
 Why?
Gene Expression
2
2012
609
0.040
 Why?
Predictive Value of Tests
2
2012
905
0.040
 Why?
Dexamethasone
1
2020
430
0.040
 Why?
Treatment Outcome
2
2020
5155
0.040
 Why?
Infant
2
2020
3563
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.040
 Why?
Dose-Response Relationship, Drug
2
2010
1378
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
89
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
202
0.030
 Why?
Cross-Sectional Studies
1
2021
1554
0.030
 Why?
Neoadjuvant Therapy
1
2017
117
0.030
 Why?
Neovascularization, Pathologic
1
2017
162
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
48
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
990
0.030
 Why?
Pilot Projects
1
2016
697
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
88
0.030
 Why?
Genome, Human
1
2013
111
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Penetrance
1
2012
6
0.030
 Why?
Neoplasm Grading
1
2012
123
0.020
 Why?
Genetic Association Studies
1
2012
116
0.020
 Why?
Anthracyclines
1
2011
29
0.020
 Why?
Vincristine
1
2011
88
0.020
 Why?
Inhibitory Concentration 50
1
2010
75
0.020
 Why?
Paclitaxel
1
2011
84
0.020
 Why?
Formazans
1
2010
2
0.020
 Why?
Tetrazolium Salts
1
2010
14
0.020
 Why?
Immunoblotting
1
2010
117
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.020
 Why?
Drug Synergism
1
2010
151
0.020
 Why?
HEK293 Cells
1
2011
224
0.020
 Why?
Michigan
1
2010
17
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
155
0.020
 Why?
Point Mutation
1
2010
65
0.020
 Why?
Neoplasm Transplantation
1
2010
85
0.020
 Why?
Epithelial Cells
1
2012
207
0.020
 Why?
Androgens
1
2010
69
0.020
 Why?
Kidney Neoplasms
1
2012
176
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Transplantation, Heterologous
1
2010
75
0.020
 Why?
BRCA2 Protein
1
2009
15
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
73
0.020
 Why?
Adenosine Triphosphate
1
2011
233
0.020
 Why?
BRCA1 Protein
1
2009
31
0.020
 Why?
Comparative Genomic Hybridization
1
2009
47
0.020
 Why?
Polymerase Chain Reaction
1
2011
454
0.020
 Why?
Proteins
1
2012
345
0.020
 Why?
Mice, Nude
1
2010
254
0.020
 Why?
Chi-Square Distribution
1
2010
278
0.020
 Why?
Cell Cycle
1
2010
232
0.020
 Why?
Algorithms
1
2013
618
0.020
 Why?
Protein Binding
1
2011
665
0.020
 Why?
Gene Deletion
1
2010
270
0.020
 Why?
Diagnosis, Differential
1
2012
1043
0.020
 Why?
Cell Survival
1
2010
602
0.020
 Why?
Incidence
1
2012
1006
0.020
 Why?
Neoplasm Invasiveness
1
2009
266
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
179
0.020
 Why?
Neoplastic Stem Cells
1
2009
103
0.020
 Why?
Promoter Regions, Genetic
1
2010
475
0.020
 Why?
Neoplasm Staging
1
2011
738
0.020
 Why?
Membrane Proteins
1
2010
353
0.020
 Why?
Microscopy, Confocal
1
2008
89
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
411
0.020
 Why?
Cell Differentiation
1
2011
650
0.020
 Why?
Chromosome Aberrations
1
2009
297
0.020
 Why?
Survival Rate
1
2010
901
0.020
 Why?
Registries
1
2010
522
0.020
 Why?
Chromosomes, Human
1
2005
41
0.020
 Why?
Time Factors
1
2010
2922
0.010
 Why?
Reproducibility of Results
1
2005
1185
0.010
 Why?
Mice
1
2010
5759
0.010
 Why?
Animals
1
2010
13246
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (236) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department